26
|
Guzman J, Bauernschmitt R, Bauer S, Grunebaum J, von Hodenberg E, Schnell C, Sodian R. Anterior Mitral Leaflet (AML) Endocarditis and Perforation after Self-expanding TAVI. Thorac Cardiovasc Surg 2018. [DOI: 10.1055/s-0038-1628110] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
27
|
Olvera O, Powell JR, de la Rosa ME, Salceda VM, Gaso MI, Guzman J, Anderson WW, Levine L. POPULATION GENETICS OF MEXICAN DROSOPHILA
VI. CYTOGENETIC ASPECTS OF THE INVERSION POLYMORPHISM IN DROSOPHILA PSEUDOOBSCURA. Evolution 2017; 33:381-395. [DOI: 10.1111/j.1558-5646.1979.tb04691.x] [Citation(s) in RCA: 29] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/1978] [Revised: 09/14/1978] [Indexed: 11/30/2022]
|
28
|
Bonella F, Lyu Y, Theegarten D, Boerner E, Wessendorf TE, Guzman J, Costabel U, Kreuter M. Potential utility of anti-DFS70 antibodies to exclude systemic autoimmune rheumatic disease (SARD) in patients with interstitial lung disease (ILD). Pneumologie 2017. [DOI: 10.1055/s-0037-1598280] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
29
|
Bonella F, Long X, Theegarten D, Boerner E, Wessendorf T, Guzman J, Costabel U. Einfluss von Nintedanib auf die Freisetzung von angiogenetischen/angiostatischen Zytokinen von Alveolarmakrophagen (AMs) bei interstitiellen Lungenerkrankungen (ILD). Pneumologie 2016. [DOI: 10.1055/s-0036-1572293] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
30
|
Cheng J, Au J, Morillo C, Guzman J, MacDonald M. CHARACTERIZATION OF ARTERIAL STIFFNESS IN PATIENTS WITH POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME AND EHLERS-DANLOS SYNDROME JOINT HYPERMOBILITY SYNDROME TYPE III. Can J Cardiol 2015. [DOI: 10.1016/j.cjca.2015.07.403] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
31
|
Deif B, Kang S, Ismail A, Vanniyasingam T, Guzman J, Morillo C. APPLYING SYNCOPE GUIDELINES TO AN EMERGENCY DEPARTMENT POPULATION IS NOT ASSOCIATED WITH A REDUCTION IN ADMISSION RATES: A RETROSPECTIVE COHORT STUDY. Can J Cardiol 2015. [DOI: 10.1016/j.cjca.2015.07.113] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
32
|
Guzman J, Tompa E, Koehoorn M, de Boer H, Macdonald S, Alamgir H. Economic evaluation of occupational health and safety programmes in health care. Occup Med (Lond) 2015; 65:590-7. [PMID: 26290408 DOI: 10.1093/occmed/kqv114] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
BACKGROUND Evidence-based resource allocation in the public health care sector requires reliable economic evaluations that are different from those needed in the commercial sector. AIMS To describe a framework for conducting economic evaluations of occupational health and safety (OHS) programmes in health care developed with sector stakeholders. To define key resources and outcomes to be considered in economic evaluations of OHS programmes and to integrate these into a comprehensive framework. METHODS Participatory action research supported by mixed qualitative and quantitative methods, including a multi-stakeholder working group, 25 key informant interviews, a 41-member Delphi panel and structured nominal group discussions. RESULTS We found three resources had top priority: OHS staff time, training the workers and programme planning, promotion and evaluation. Similarly, five outcomes had top priority: number of injuries, safety climate, job satisfaction, quality of care and work days lost. The resulting framework was built around seven principles of good practice that stakeholders can use to assist them in conducting economic evaluations of OHS programmes. CONCLUSIONS Use of a framework resulting from this participatory action research approach may increase the quality of economic evaluations of OHS programmes and facilitate programme comparisons for evidence-based resource allocation decisions. The principles may be applicable to other service sectors funded from general taxes and more broadly to economic evaluations of OHS programmes in general.
Collapse
|
33
|
Guzman J, Kerr T, Ward L, Ma J, Oen K, Boire G, Feldman B, Scuccimarri R, Houghton K, Bruns A, Dancey P, Rosenberg A, Tucker L. SAT0507 Growth and Weight Gain in Children with Juvenile Idiopathic Arthritis: Results from the Reacch-Out Cohort. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.2400] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
34
|
Guzman J, Loughin T, Henrey A, Berard R, Shiff N, Jurencak R, Benseler S, Tucker L. FRI0499 Using Patient-Relevant Variables to Describe the Disease Course in Children with Juvenile Idiopathic Arthritis: Results from the Reacch-Out Cohort: Table1. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.2396] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
35
|
Beukelman T, Berntson L, Duffy C, Guzman J, Kimura Y, Klotsche J, Magnusson B, Minden K, Nordal E, Santos M, Thomson W, Zilhao C, Hyrich K. THU0531 The Initial Treatment of Systemic Juvenile Idiopathic Arthritis: An International Collaboration Among 7 Registries:. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.1613] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
36
|
Soled S, Miseo S, Baumgartner J, Guzman J, Bolin T, Meyer R. Can Ni phosphides become viable hydroprocessing catalysts? Catal Today 2015. [DOI: 10.1016/j.cattod.2014.05.049] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
37
|
Bonella F, Sixt S, Thomassen J, Schmidt M, Cai M, Mori T, Guzman J, Costabel U. Extracellular 20S proteasome in BAL and serum of patients with alveolar proteinosis. Immunobiology 2015; 220:382-8. [DOI: 10.1016/j.imbio.2014.10.010] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2014] [Revised: 09/17/2014] [Accepted: 10/12/2014] [Indexed: 10/24/2022]
|
38
|
Kamper SJ, Apeldoorn AT, Chiarotto A, Smeets RJEM, Ostelo RWJG, Guzman J, van Tulder MW. Multidisciplinary biopsychosocial rehabilitation for chronic low back pain: Cochrane systematic review and meta-analysis. BMJ 2015; 350:h444. [PMID: 25694111 PMCID: PMC4353283 DOI: 10.1136/bmj.h444] [Citation(s) in RCA: 562] [Impact Index Per Article: 62.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
OBJECTIVE To assess the long term effects of multidisciplinary biopsychosocial rehabilitation for patients with chronic low back pain. DESIGN Systematic review and random effects meta-analysis of randomised controlled trials. DATA SOURCES Electronic searches of Cochrane Back Review Group Trials Register, CENTRAL, Medline, Embase, PsycINFO, and CINAHL databases up to February 2014, supplemented by hand searching of reference lists and forward citation tracking of included trials. STUDY SELECTION CRITERIA Trials published in full; participants with low back pain for more than three months; multidisciplinary rehabilitation involved a physical component and one or both of a psychological component or a social or work targeted component; multidisciplinary rehabilitation was delivered by healthcare professionals from at least two different professional backgrounds; multidisciplinary rehabilitation was compared with a non- multidisciplinary intervention. RESULTS Forty one trials included a total of 6858 participants with a mean duration of pain of more than one year who often had failed previous treatment. Sixteen trials provided moderate quality evidence that multidisciplinary rehabilitation decreased pain (standardised mean difference 0.21, 95% confidence interval 0.04 to 0.37; equivalent to 0.5 points in a 10 point pain scale) and disability (0.23, 0.06 to 0.40; equivalent to 1.5 points in a 24 point Roland-Morris index) compared with usual care. Nineteen trials provided low quality evidence that multidisciplinary rehabilitation decreased pain (standardised mean difference 0.51, -0.01 to 1.04) and disability (0.68, 0.16 to 1.19) compared with physical treatments, but significant statistical heterogeneity across trials was present. Eight trials provided moderate quality evidence that multidisciplinary rehabilitation improves the odds of being at work one year after intervention (odds ratio 1.87, 95% confidence interval 1.39 to 2.53) compared with physical treatments. Seven trials provided moderate quality evidence that multidisciplinary rehabilitation does not improve the odds of being at work (odds ratio 1.04, 0.73 to 1.47) compared with usual care. Two trials that compared multidisciplinary rehabilitation with surgery found little difference in outcomes and an increased risk of adverse events with surgery. CONCLUSIONS Multidisciplinary biopsychosocial rehabilitation interventions were more effective than usual care (moderate quality evidence) and physical treatments (low quality evidence) in decreasing pain and disability in people with chronic low back pain. For work outcomes, multidisciplinary rehabilitation seems to be more effective than physical treatment but not more effective than usual care.
Collapse
|
39
|
Long X, Costabel U, He X, Guzman J, Theegarten D, Bonella F. Serum YKL-40 as a candidate biomarker for hypersensitivity pneumonitis. Pneumologie 2015. [DOI: 10.1055/s-0035-1544609] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
40
|
Börner E, Bonella F, Theegarten D, Wessendorf T, Guzman J, Costabel U. Pleuroparenchymal fibroelastosis – a new diagnostic and therapeutic challenge for pneumologists. Pneumologie 2014. [DOI: 10.1055/s-0034-1367971] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
41
|
Moran M, Guzman J, Ropars AL, Illmer A. The role of Product Development Partnerships in research and development for neglected diseases. Int Health 2013; 2:114-22. [PMID: 24037470 DOI: 10.1016/j.inhe.2010.04.002] [Citation(s) in RCA: 42] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
Product Development Partnerships (PDPs) are playing an increasingly important role in the development of new medicines for neglected diseases of the developing world; however, there has been limited information on their funding and expenditure patterns. This paper analyses funding for the 14 PDPs working on neglected disease research and development (R&D) by using unpublished data from the Global Funding of Innovation for Neglected Diseases (G-FINDER) project, which surveyed 2007 global investments into R&D of products for neglected diseases. PDPs captured US$469 million or 23% of 'external' R&D funding for neglected diseases, i.e. funding granted by donors to research organisations, as opposed to internal investments by donors. PDP's funding sources were highly concentrated with the Gates Foundation providing nearly half of PDPs' combined income (49%) and four public funders (the US Agency for International Development (USAID), the UK Department for International Development (DFID), the Dutch government and Irish Aid) providing 28%. PDPs collectively spent US$262 million on R&D activities in 2007, with 88% of this expenditure going to academic institutions, contract research organisations and companies in the developed world. Our analysis confirms the central role played by PDPs in R&D for neglected diseases, but highlights the need to diversify their funding sources.
Collapse
|
42
|
|
43
|
Bonella F, Theegarten D, Worm K, Wessendorf T, Guzman J, Costabel U. Beeinflussung der Serum YKL-40 Konzentration bei Patienten mit Alveolarproteinose durch Chitinase 3-like 1 Genpolymorphismen. Pneumologie 2013. [DOI: 10.1055/s-0033-1334685] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
44
|
Chin A, Velasco A, Guzman J, Morillo C. 603 The Efficacy and Safety of Vernakalant - A Meta-Analysis of Randomised Clinical Trials. Can J Cardiol 2012. [DOI: 10.1016/j.cjca.2012.07.541] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
45
|
Cai M, Bonella F, Dai H, Guzman J, Costabel U. Macrolides inhibit cytokine production by alveolar macrophages in bronchiolitis obliterans organizing pneumonia. Pneumologie 2012. [DOI: 10.1055/s-0032-1302796] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
46
|
Bonella F, Cai M, Ohshimo S, Guzman J, Costabel U. Serum YKL-40 als prädiktiver Biomarker der Krankheitsprogression bei Patienten mit Alveolarproteinose. Pneumologie 2012. [DOI: 10.1055/s-0032-1302795] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
47
|
Guzman J, Silvanto J, Seemungal B. PTMS64 Motion adaptation increases the susceptibility of the motion selective-area V5/MT to phosphene induction by transcranial magnetic stimulation. Clin Neurophysiol 2011. [DOI: 10.1016/s1388-2457(11)60717-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
48
|
Seemungal B, Guzman J, Arshad Q, Walsh V, Bronstein A. PTMS61 Vestibular activation differentially affects excitability in human visual cortex areas V1 and V5/MT. Clin Neurophysiol 2011. [DOI: 10.1016/s1388-2457(11)60714-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
49
|
Cai M, Sixt S, Bonella F, Anlasik T, Mori T, Guzman J, Costabel U. Up-regulated expression of immunoproteasome subunit LMP7 in alveolar macrophages of hypersensitivity pneumonitis. Pneumologie 2011. [DOI: 10.1055/s-0031-1271995] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
50
|
Bonella F, Sixt S, Anlasik T, Bauer P, Guzman J, Costabel U. Extrazelluläres Proteasom in der BAL von Patienten mit Alveolarproteinose. Pneumologie 2011. [DOI: 10.1055/s-0031-1272154] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|